Julian Gough

Julian Gough has extensive experience in the field of biotech and computer science. Julian is currently the Chief Scientific Advisor at Mogrify, a data-driven Cell Therapy biotech start-up. Prior to this, Julian held multiple roles at Mogrify, including Founder, CTO, Founder, CSO, and Founder, CEO. In these positions, they were responsible for various leadership and advisory roles within the company.

In addition to their work at Mogrify, Julian is also the Founder and CEO of Snowflake Biotech since 2017. Julian founded this company and has been leading it as CEO since its inception.

Before their work with these start-ups, Julian served as a Programme Leader at the MRC Laboratory of Molecular Biology (LMB). In this role, they led a team of post-docs and PhD students in research programs focused on cell reprogramming and human genetics using computational and data-driven approaches.

Julian's academic career includes a position as an Honorary Professor of Computer Science at the University of Bristol from 2007 to 2017. Prior to that, they served as a Professor of Computer Science at the same institution, where they conducted research, taught and administered academic responsibilities.

Julian has also been involved in founding and directing other companies, such as Genetrainer and Bed Sense, where they held director and co-founder roles.

Throughout their career, Julian has also gained research experience as a Visiting Scientist at Institut Pasteur, a Research Scientist at RIKEN, a Research Fellow at Stanford University, and a Research Associate at the MRC Laboratory of Molecular Biology (LMB).

Overall, Julian Gough has a strong background in both biotech and computer science, with significant experience in leadership, research, and innovation.

Julian Gough started their education at The Perse School in Cambridge in 1982 and completed it in 1993. Julian then attended the University of Bristol from 1994 to 1998, where they earned their MSci degree in Physics and Mathematics. After that, they pursued a PhD in Theoretical and Computational Molecular Biology at the University of Cambridge from 1998 to 2001. Following their PhD, they went on to Stanford University School of Medicine as a research fellow in Computational Biology from 2001 to 2003.